Skip to Content

THURSDAY, 05 MARCH 2026, 13:31

Top Stories

Mexico steps up investigations into fuel smuggling by drug cartels

Today at 13:22 PM, via Daily Maverick

Mexico has expanded a probe into fuel smuggling at sea ports highlighted in a 2025 Reuters investigation into cartel-linked fuel crimes, according to a government document reviewed by the news agency outlining actions taken by the administration.

World

Ukraine offers drone expertise to Gulf amid Iran strikes

Today at 11:48 AM, via NPR

As Iran launches its Shahed drones at Gulf nations in retaliation for strikes by the U.S. and Israel, Ukraine offers its expertise at downing the drones Russia has lobbed at its cities for years.

World

China offers to mediate in US-Israel-Iran war

Today at 11:47 AM, via NPR

China says it will send a special envoy to the Middle East to help mediate the US-Israel-Iran war, as Chinese political elites gather in Beijing for the annual “Two Sessions.”

Science/Tech

DA Takes Court Action To Stop Above-Inflation Salary Hikes At Struggling City Of Johannesburg

Today at 13:14 PM, via Tech Financials

The Democratic Alliance (DA) has initiated legal action against the City of Johannesburg to halt what the party claims is the implementation of an unfunded R10 billion salary agreement. Councillor Belinda Kayser-Echeozonjoku, the DA Johannesburg Caucus Leader, on Wednesday, 4 March 2026, said her party, ”served the City with legal papers to stop the implementation […]

Science/Tech

The Next Gender Gap Is Time

Today at 12:47 PM, via Tech Financials

A country reveals who holds power by watching who gets to wait. Waiting is often framed as a minor inconvenience, yet it functions as a gatekeeper. It signals whose time is treated as valuable and whose time can be absorbed by the system, and that is where rights and justice often break down in practice. […]

Health

F.D.A. Faces Upset Over Denials of New Drugs

Today at 12:01 PM, via New York Times

Agency officials promise fast reviews of new treatments while vowing they will not be a “rubber stamp” for the industry. But patients with rare diseases view recent decisions as signs that the doors are closing on their options.